Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.71M Buy
38,900
+31,100
+399% +$2.99M ﹤0.01% 1982
2026
Q1
$808K Sell
7,800
-25,700
-77% -$2.91M ﹤0.01% 2884
2025
Q4
$3.38M Buy
33,500
+31,600
+1,663% +$3.43M ﹤0.01% 2114
2025
Q3
$234K Buy
+1,900
New +$236K ﹤0.01% 2106
2025
Q2
Sell
-48,500
Closed -$7.14M 2242
2025
Q1
$7.14M Buy
48,500
+46,100
+1,921% +$7.04M 0.02% 797
2024
Q4
$390K Hold
2,400
﹤0.01% 1725
2024
Q3
$391K Hold
2,400
﹤0.01% 1664
2024
Q2
$328K Buy
+2,400
New +$333K ﹤0.01% 1523
2023
Q2
Sell
-3,600
Closed -$570K 2242
2023
Q1
$570K Hold
3,600
﹤0.01% 1208
2022
Q4
$505K Hold
3,600
﹤0.01% 1149
2022
Q3
$462K Buy
+3,600
New +$519K ﹤0.01% 1179

Other funds holding CLX

Steven Cohen's CLX Position: Q2 2026 in Review

Steven Cohen sold out of Clorox (CLX) in Q2 2026, closing a stake of 1,592,288 shares — an estimated $153M sold.

Steven Cohen first reported a position in CLX in Q2 2017 and held it in 11 quarters. The position peaked at $179M in Q1 2024. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Steven Cohen reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 1,592,288 Clorox shares in Q2 2026, an estimated $153M.
  • Steven Cohen first reported a position in Clorox in Q2 2017 and held it in 11 quarters.
  • Steven Cohen's Clorox position peaked at $179M in Q1 2024.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.